Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Stefan Perthaler - Process Team Lead Biofuture Plant1 at Novartis | The Org
Novartis investiert weiter in Biopharmazeutika-Kompetenzzentrum ...
Novartis licenses radiopharma asset from Chinese biotech for $50M upfront
2024 Photo Gallery | BioFuture
Novartis 2025: Strengthening foundations and delivering returns ...
Novartis declares positive results from phase III study for new malaria ...
Novartis to Acquire Avidity Biosciences for About $12 Billion
Novartis BIOME UK announces selection for the HealthHub 21 Challenge ...
Novartis expands its biopharmaceutical manufacturing site in Singapore ...
Novartis Unveils Groundbreaking Gene Therapy Facility - The Region
Novartis to acquire German Biotech MorphoSys for $2.9B, Expanding ...
Novartis Announces $23 Billion US Investment - PharmaSource
Transforming Processes at Novartis Stein for a Competitive Future
Novartis Nears Deal to Acquire Avidity Biosciences for Over $70 Per ...
BioFuture - The new age of healthcare and technology – Health Podcast ...
Novartis Enters into Deal with Legend Biotech for $100 Million Upfront ...
Novartis | PPTX
2023 Photo Gallery | BioFuture
FDA approves Novartis combo therapy for aggressive type of thyroid cancer
About | Novartis
Capabilities factsheet | Novartis Global Biotech Cooperations | CPHI Online
Novartis breast cancer drug gets FDA fast track, takes on Pfizer | Fox News
Novartis expands in cardiovascular disease with $1.4bn Tourmaline Bio ...
Novartis Pipeline | Novartis
Novartis Global Biotech Cooperations - BIO International Convention | BIO
BioFuture Returns to New York City October 28-30 with the Launch of ...
BioFuture - October 4-6, 2023 NYC - FreeMind Group
Biofuture Platform launches five principles for post-COVID bioeconomy ...
Samsung Biologics signs $390.9 million deal with Novartis | Companies ...
BioFuture 2025 | VirginiaBio
FDA recommends Novartis biosimilar of Amgen’s drug Neupogen | Life ...
How Novartis Is Shaping the Future of Lab Automation Through Smart ...
Novartis strikes deal with UK biotech for up to US$1.7 billion - The ...
Novartis to buy Avidity Biosciences in $12B deal to boost rare disease ...
Novartis launches Biome India, a digital innovation hub in Hyderabad ...
Novartis at The American Biomanufacturing Summit 2024 - YouTube
Novartis buys a preclinical biotech and its RNA drug technology ...
Project : Novartis - Big Image Group Pte Ltd
Novartis Novartis Hi Res Stock Photography And Images Alamy
Novartis reports data from Phase IIIb trial of SMA therapy
Novartis licenses RNA drugs in deal with China-based Argo | BioPharma Dive
Finding new ways to deliver breakthrough treatments. Novartis returns ...
Novartis to buy France's CellforCure to boost cell, gene therapy ...
XTX Topco Ltd Sells 8,098 Shares of Novartis AG (NYSE:NVS)
Cosentyx Becomes First Novartis Medicine Offered at 55% Discount ...
Novartis lifts guidance after first-quarter results beat expectations
MC Services supports BioFuture 2023 • MC Services
Healthcare firm Novartis to acquire biotech startup Avidity for $12b
Novartis ‘nears’ deal to acquire Avidity Biosciences for more than $70 ...
Biofuture - UK Map Guide
Basel, Switzerland - May 18, 2024: Headquarters of Novartis or Novartis ...
Neuro Biotech Scooped Up by Novartis in $770 Million Deal - DistilINFO ...
Photo Gallery | BioFuture
Biotech Stock Chinook Skyrockets On $3.5 Billion Novartis Takeover ...
See Whos Attending in 2023 | BioFuture
Novartis to buy Avrobio gene therapy for $88M, leaving rest of the ...
Novartis Biopharm Manufacturing Starts in Singapore
Novartis transformation into a pure-play Innovative Medicines company ...
Biofuture - New York City - 4th - 6th October 2023 - VALOS ...
Novartis secures PBS recommendation for Beovu - Insight
Biofourmis and Novartis planning Digital Heart Failure Project ...
Pharmariese Novartis baut im Aargau 550 Stellen ab | Nau.ch
Novartis CEO Targets 20 Key Drugs as Potential Blockbusters - DCAT ...
Novartis Bolsters Retinal Gene Therapy Position with Gyroscope ...
2022 Photo Gallery | BioFuture
Biothérapies : Novartis va investir 300 millions de dollars en Europe
Novartis Biome and Legit.Health team up for digital health innovation ...
Novartis builds case for new SMA gene therapy | BioPharma Dive
Partnering | Novartis
Novartis acquisisce Anthos Therapeutics per 925 milioni di dollari
Novartis to acquire Tourmaline Bio in a deal worth $1.4bn - PMLiVE
Novartis weighs deal for biotech Avidity Biosciences, FT reports | Reuters
KRUPITSKY - Novartis Biome
Novartis Continues RNA & Neuroscience Growth Strategy With $12B Avidity ...
Novartis Exceeds Q1 Forecasts, Boosts Outlook as Blockbuster Drug Sales ...
Novartis plans $771M investment in RTP, bringing as many as 700 new ...
Creating the Infrastructure & Regulation for a Sustainable Biofuture
BioNTech buys German site from Novartis to boost vaccine output ...
VIP Forum: Novartis 2020 - Life Science Washington Institute
Brinter presenting at Biofuture October 4-6, 2023 in NYC
Novartis Acquiring US Firm Avidity Biosciences for $12 Bn
Social Media Tools | BioFuture
Biofuture Platform | Clean Energy Ministerial
Novartis to Acquire US Biotech Avidity Biosciences in $12 Billion All ...
"Großes Damoklesschwert" über Penicillin-Produktion in Tirol | Kurier
Biotech M&A slowed in Massachusetts amid economic uncertainty - Boston ...
Novartis' cell therapy ambitions outpace early returns | BioPharma Dive
Generate:Biomedicines Announces Multi-Target Collaboration with ...
Novartis’ Ianalumab Earns FDA Breakthrough Status in Sjögren’s Disease ...
BioFuture™ 2025 Explores the Next Era of Innovation, Policy, and ...
Pharmaceutical Technology
July 6 2022
Novartis, Argo Biopharma expand strategic alliance with USD 5.2 billion ...
Novartis: Transforming cancer with Beyond The Pill Solutions
Novartis’ breast cancer therapy wins FDA breakthrough designation
BioFuture™ Conference 2021 Launch in New York City Inspires Innovation ...
BioFuture™ 2023 Wraps Up After Convening Hundreds of High-Profile ...
Novartis’ Fabhalta is first FDA-cleared oral therapy for PNH | pharmaphorum
New Weapon in Push to Lower U.S. Biotech Drug Prices - WSJ
BioFuture™ 2024 Tackles the Industry's Critical Challenges and ...
News and Events – BioFuturePlatform
Biofuture, a Demy-Colton Event - FreeMind Group
BioFuturePlatform – Accelerate the transition to a global bioeconomy
BioFuture™ Conference Brings Together Stakeholders In Transformative ...
European Biotechnology Magazine
:max_bytes(150000):strip_icc()/GettyImages-458951947-29e3572b4d094cabbdc1e8eeb0074b9a.jpg)
:max_bytes(150000):strip_icc()/GettyImages-1244662972-6c92522b2e9d48ada3788062940cec51.jpg)
